Association between nicotine withdrawal and reward responsiveness in humans and rats
- PMID: 25208057
- PMCID: PMC4353576
- DOI: 10.1001/jamapsychiatry.2014.1016
Association between nicotine withdrawal and reward responsiveness in humans and rats
Abstract
Importance: Reward-related disturbances after withdrawal from nicotine are hypothesized to contribute to relapse to tobacco smoking but mechanisms underlying and linking such processes remain largely unknown.
Objective: To determine whether withdrawal from nicotine affects reward responsiveness (ie, the propensity to modulate behavior as a function of prior reinforcement experience) across species using translational behavioral assessments in humans and rats.
Design, setting, participants: Experimental studies used analogous reward responsiveness tasks in both humans and rats to examine whether reward responsiveness varied in (1) an ad libitum smoking condition compared with a 24-hour acute nicotine abstinence condition in 31 human smokers with (n = 17) or without (n = 14) a history of depression; (2) rats 24 hours after withdrawal from chronic nicotine (n = 19) or saline (n = 20); and (3) rats following acute nicotine exposure after withdrawal from either chronic nicotine or saline administration.
Main outcomes and measures: Performance on a reward responsiveness task under nicotine and nonnicotine conditions.
Results: In both human smokers and nicotine-treated rats, reward responsiveness was significantly reduced after 24-hour withdrawal from nicotine (P < .05). In humans, withdrawal-induced deficits in reward responsiveness were greater in those with a history of depression. In rats previously exposed to chronic nicotine, acute nicotine reexposure long after withdrawal potentiated reward responsiveness (P < .05).
Conclusions and relevance: These findings across species converge in suggesting that organisms have diminished ability to modulate behavior as a function of reward during withdrawal of nicotine. This blunting may contribute to relapse to tobacco smoking, particularly in depression-vulnerable individuals, to reinstate responsiveness to natural rewards and to experience potentiated nicotine-induced reward responsiveness. Moreover, demonstration of behavioral homology across humans and rodents provides a strong translational framework for the investigation and development of clinical treatments targeting reward responsiveness deficits during early withdrawal of nicotine.
Figures
References
-
- Centers for Disease Control (CDC). Cigarette Smoking-Attributable Morbidity-United Staes, 2000. Morbidity and Mortality Weekly. 2003;52:842–844. - PubMed
-
- Ferguson SG, Shiffman S, Gwaltney CJ. Does reducing withdrawal severity mediate nicotine patch efficacy? A randomized clinical trial. J Consult Clin Psychol. 2006;74:1153–1161. - PubMed
-
- Cummings KM, Jaen CR, Giovino G. Circumstances surrounding relapse in a group of recent exsmokers. Prev Med. 1985;14:195–202. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- DA019951/DA/NIDA NIH HHS/United States
- R21 MH078979/MH/NIMH NIH HHS/United States
- K05 AA017688/AA/NIAAA NIH HHS/United States
- R56 DA012854/DA/NIDA NIH HHS/United States
- R01 DA011946/DA/NIDA NIH HHS/United States
- R56 DA011946/DA/NIDA NIH HHS/United States
- DA011946/DA/NIDA NIH HHS/United States
- R01 DA012854/DA/NIDA NIH HHS/United States
- K08 DA019951/DA/NIDA NIH HHS/United States
- AA017688/AA/NIAAA NIH HHS/United States
- MH078979/MH/NIMH NIH HHS/United States
- R01 MH068376/MH/NIMH NIH HHS/United States
- DA012854/DA/NIDA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
